Table 1.
Authors | Design | Sample size | Outcome |
Corney et al[62] (1991) | CBT vs SMT. FU at 4 & 9 mo | 42 | CBT = SMT |
Greene et al[64] (1994) | CBT vs SMT. FU at 3 mo | 20 | CBT > SMT |
Payne et al[65] (1995) | CBT vs Self-help support group vs SMT. FU at 3 mo | 34 | CBT > Self-help > SMT |
Drossman et al[68] (2003) | CBT vs education, and desipramine vs placebo (parallel studies). No FU | 431 | CBT > education; desipramine: placebo |
Boyce et al[61] (2003) | CBT vs relaxation training vs SMT. FU at 12 mo | 105 | CBT = Relaxation training = SMT |
Blanchard et al[66] (2007) | Group CBT vs Self-help support group vs SMT. FU at 3 mo | 210 | CBT = Support group > SMT |
Kennedy et al[63] (2006) | Multicenter primary care intervention by nurses. Open label. CBT + mebeverine vs mebeverine alone. | 149 | CBT + mebeverine > Mebeverine alone at 3 & 6 mo FU |
SMT: standard medical care with symptom self-monitoring; FU = follow up; Mebeverine: anticholinergic for inhibition of smooth muscle contractions.